Showing results (131-140 of 374) with videos related to

Sort By:
Pageof 38
Research in Developmental Disabilities|August 12, 2011
Quantifying peer interactions for research and clinical use: the Manchester Inventory for Playground ObservationJenny Gibson, Jamilla Hussain, Samina Holsgrove, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 27, 2025
Evaluating the Study Designs and Outcome Measures Used in Service User Involvement in Health Professional Entry-Level Education: A Systematic ReviewJonathan Green, Jennifer Oates, Sam Robertson, et al.
Journal of Emergency Nursing|June 24, 2026
Emergency Nurse-Led Evidence-Based Practice Initiative: Patient Self-Management of Noncommunicable Disease in the CommunityW K Johnson Tse, Jonathan Green, C Y Jane Yau
European Child & Adolescent Psychiatry|April 24, 2008
Do larger studies find smaller effects? The example of studies for the prevention of conduct disorderBrid McMahon, Louise Holly, Richard Harrington, et al.
Nucleic Acids Research|November 30, 2006
HepSEQ: International Public Health Repository for Hepatitis BSaravanamuttu Gnaneshan, Samreen Ijaz, Joanne Moran, et al.
Plos One|July 1, 2024
An analysis of NHS 111 demand for primary care services: A retrospective cohort studyRichard Pilbery, Madeleine Smith, Jonathan Green, et al.
Journal of Neurodevelopmental Disorders|August 13, 2016
Sex bias in autism spectrum disorder in neurofibromatosis type 1Shruti Garg, Hein Heuvelman, Susan Huson, et al.
Journal of Autism and Developmental Disorders|November 16, 2013
Restricted and repetitive behaviors in autism spectrum disorders and typical development: cross-sectional and longitudinal comparisonsClare Harrop, Helen McConachie, Richard Emsley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Serum osteoprotegerin levels in healthy controls and cancer patientsAllan Lipton, Suhail M Ali, Kim Leitzel, et al.
Journal of Bone Oncology|March 4, 2022
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approvalBenoit Cadieux, Robert Coleman, Pegah Jafarinasabian, et al.
Pageof 38